Differential response of hepatocellular carcinoma glycolytic metabolism and oxidative stress markers after exposure to human amniotic membrane proteins-Reference-Cited by-同舟云学术

Differential response of hepatocellular carcinoma glycolytic metabolism and oxidative stress markers after exposure to human amniotic membrane proteins

Published:2022-06-18 Issue:8 Volume:49 Page:7731-7741
ISSN:0301-4851
Container-title:Molecular Biology Reports
language:en
Short-container-title:Mol Biol Rep

Author:

Alves Andreia P,Rocha Sandra M,Mamede Ana C,Braga Patrícia C,Alves Marco G,Oliveira Pedro F,Botelho Filomena M,Maia Cláudio J^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Genetics,Molecular Biology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s11033-022-07598-5.pdf

Reference45 articles.

1. McGlynn KA, Petrick JL, El-Serag HB (Jan. 2021) Epidemiology of Hepatocellular Carcinoma. Hepatology 73(4). no. Suppl 1doi: https://doi.org/10.1002/HEP.31288

2. Petrick JL et al (2020) “International trends in hepatocellular carcinoma incidence, 1978–2012,” Int. J. cancer, vol. 147, no. 2, pp. 317–330, doi: https://doi.org/10.1002/IJC.32723

3. McGlynn KA, Petrick JL, London WT (May 2015) Global epidemiology of hepatocellular carcinoma: an emphasis on demographic and regional variability. ” Clin Liver Dis 19(2):223–238. doi: https://doi.org/10.1016/j.cld.2015.01.001

4. Alqahtani A, Khan Z, Alloghbi A, Ahmed TSS, Ashraf M, Hammouda DM (Sep. 2019) Hepatocellular Carcinoma: Molecular Mechanisms and Targeted Therapies. Med (Kaunas) 55(9). doi: https://doi.org/10.3390/MEDICINA55090526

5. Burkhart RA, Ronnekleiv-Kelly SM, Pawlik TM (Jun. 2017) Personalized therapy in hepatocellular carcinoma: Molecular markers of prognosis and therapeutic response. Surg Oncol 26(2):138–145. doi: https://doi.org/10.1016/J.SURONC.2017.01.009

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Application of the Human Amniotic Membrane as an Adjuvant Therapy for the Treatment of Hepatocellular Carcinoma;Advances in Experimental Medicine and Biology;2023